HLA-DRA and disease arising from reactivation of latent virus: Unexpectedly we also observed that the levels of HLA-DRα, DRβ, and DQα were presented consistently lower after LANA inhibition, while the levels of vIRF3 (a viral antigen previously shown to inhibit MHC II in latent infection [38]) were slightly enhanced (Figure 4B).